Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000728736 | SCV000856345 | uncertain significance | not provided | 2017-08-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001868935 | SCV002303403 | likely benign | Familial hypocalciuric hypercalcemia; Autosomal dominant hypocalcemia 1 | 2023-07-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004026952 | SCV002682995 | likely benign | Nephrolithiasis/nephrocalcinosis | 2020-03-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV005027900 | SCV005657396 | uncertain significance | Familial hypocalciuric hypercalcemia 1; Neonatal severe primary hyperparathyroidism; Epilepsy, idiopathic generalized, susceptibility to, 8; Autosomal dominant hypocalcemia 1 | 2023-12-27 | criteria provided, single submitter | clinical testing |